Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Clinical results reported for Onco TCS

Nov. 17, 1997

VEGF inhibitors discovered by Zeneca

Nov. 17, 1997

NIH seeks licensees for raf protein kinase therapeutics

Nov. 17, 1997

Ribozyme, Chiron initiate product development of RPI-4610

Nov. 14, 1997

ImClone receives SBIR grant for angiogenesis research

Nov. 14, 1997

Potent antineoplastic camptothecin derivative identified

Nov. 14, 1997

TK inhibitors under development at Dr. Karl Thomae

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

Mitsui Toatsu reveals novel antitumor agents

Nov. 12, 1997

Radicicol derivatives with antitumor activity from Sankyo

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...